2014 Q4 Form 10-K Financial Statement

#000162828016011728 Filed on February 25, 2016

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2014 Q2
Revenue $197.7M $52.05M $47.17M
YoY Change 488.93% 123.78% 175.16%
Cost Of Revenue $77.44M $20.39M $19.95M
YoY Change 321.42% 37.86% 95.36%
Gross Profit $120.2M $31.66M $27.21M
YoY Change 691.6% 273.84% 292.83%
Gross Profit Margin 60.82% 60.82% 57.69%
Selling, General & Admin $106.7M $28.22M $24.84M
YoY Change 428.03% 84.18% 76.4%
% of Gross Profit 88.72% 89.13% 91.28%
Research & Development $18.73M $4.425M $5.216M
YoY Change 290.23% -25.78% 7.39%
% of Gross Profit 15.58% 13.98% 19.17%
Depreciation & Amortization $10.04M $2.300M $2.300M
YoY Change 490.29% 187.5% 187.5%
% of Gross Profit 8.35% 7.27% 8.45%
Operating Expenses $202.8M $53.03M $50.01M
YoY Change 367.53% 47.02% 71.54%
Operating Profit -$5.165M -$985.0K -$2.842M
YoY Change -81.68% -92.31% -76.34%
Interest Expense $8.278M $2.037M $2.079M
YoY Change -535.68% 7.66% 8.62%
% of Operating Profit
Other Income/Expense, Net -$8.378M -$2.019M -$2.195M
YoY Change 2692.67% 2.49% 8.61%
Pretax Income -$13.54M -$3.004M -$5.037M
YoY Change 12.86% -79.68% -64.1%
Income Tax $173.0K $0.00 $0.00
% Of Pretax Income
Net Earnings -$13.72M -$3.004M -$5.037M
YoY Change 14.72% -79.68% -64.1%
Net Earnings / Revenue -6.94% -5.77% -10.68%
Basic Earnings Per Share -$0.39 -$0.08 -$0.14
Diluted Earnings Per Share -$0.39 -$0.08 -$0.14
COMMON SHARES
Basic Shares Outstanding 35.30M shares 35.94M shares 35.46M shares
Diluted Shares Outstanding 35.30M shares 35.94M shares 35.46M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $156.7M $149.7M $163.9M
YoY Change 117.04% 83.01% 70.73%
Cash & Equivalents $37.52M $17.76M $108.2M
Short-Term Investments $119.1M $132.0M $55.70M
Other Short-Term Assets $6.000M $5.300M $5.300M
YoY Change 36.36% 17.78% 47.22%
Inventory $29.26M $23.66M $19.19M
Prepaid Expenses
Receivables $22.37M $20.52M $20.55M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $214.3M $199.2M $208.9M
YoY Change 100.71% 78.39% 71.95%
LONG-TERM ASSETS
Property, Plant & Equipment $60.63M $56.15M $53.51M
YoY Change 25.84% 22.21% 27.22%
Goodwill $23.76M $22.05M $12.52M
YoY Change 130.06% 131.14% 39.42%
Intangibles
YoY Change
Long-Term Investments $24.40M $24.50M $13.50M
YoY Change
Other Assets $2.588M $2.948M $3.103M
YoY Change -23.93% -17.12% -16.41%
Total Long-Term Assets $111.8M $106.2M $83.17M
YoY Change 77.29% 74.85% 46.07%
TOTAL ASSETS
Total Short-Term Assets $214.3M $199.2M $208.9M
Total Long-Term Assets $111.8M $106.2M $83.17M
Total Assets $326.1M $305.4M $292.1M
YoY Change 92.01% 77.15% 63.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.758M $7.747M $3.145M
YoY Change 120.2% 396.92% 83.7%
Accrued Expenses $28.31M $23.38M $23.04M
YoY Change 58.29% 50.15% 87.89%
Deferred Revenue
YoY Change
Short-Term Debt $103.1M $102.1M $101.0M
YoY Change 4.14% 4.29%
Long-Term Debt Due $120.0M $600.0K $900.0K
YoY Change 0.0% -33.33% 0.0%
Total Short-Term Liabilities $140.0M $135.2M $129.5M
YoY Change 14.82% 15.6% 717.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.409M $5.235M $4.384M
YoY Change 69.56% 79.84% 59.83%
Total Long-Term Liabilities $5.409M $5.235M $4.384M
YoY Change 69.56% 79.84% -95.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $140.0M $135.2M $129.5M
Total Long-Term Liabilities $5.409M $5.235M $4.384M
Total Liabilities $154.9M $150.3M $144.1M
YoY Change 20.5% 21.94% 20.81%
SHAREHOLDERS EQUITY
Retained Earnings -$310.1M -$315.9M -$312.9M
YoY Change 4.63% 11.06% 16.04%
Common Stock $36.00K $36.00K $36.00K
YoY Change 5.88% 5.88% 9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 0.000 shares 0.000 shares 0.000 shares
Shareholders Equity $171.1M $155.1M $148.0M
YoY Change
Total Liabilities & Shareholders Equity $326.1M $305.4M $292.1M
YoY Change 92.01% 77.15% 63.69%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2014 Q2
OPERATING ACTIVITIES
Net Income -$13.72M -$3.004M -$5.037M
YoY Change 14.72% -79.68% -64.1%
Depreciation, Depletion And Amortization $10.04M $2.300M $2.300M
YoY Change 490.29% 187.5% 187.5%
Cash From Operating Activities $14.10M $8.980M $8.220M
YoY Change -304.35% -191.26% -161.76%
INVESTING ACTIVITIES
Capital Expenditures $22.98M -$4.950M -$6.020M
YoY Change -920.86% 5.32% 245.98%
Acquisitions
YoY Change
Other Investing Activities $11.13M -$96.86M -$24.55M
YoY Change -38.24% -1265.58% 549.47%
Cash From Investing Activities $2.930M -$101.8M -$30.58M
YoY Change -80.75% -2919.94% 453.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.740M 2.380M 111.8M
YoY Change 234.15% 142.86% 9374.58%
NET CHANGE
Cash From Operating Activities 14.10M 8.980M 8.220M
Cash From Investing Activities 2.930M -101.8M -30.58M
Cash From Financing Activities 2.740M 2.380M 111.8M
Net Change In Cash 19.77M -90.44M 89.44M
YoY Change 116.3% 1622.67% -606.74%
FREE CASH FLOW
Cash From Operating Activities $14.10M $8.980M $8.220M
Capital Expenditures $22.98M -$4.950M -$6.020M
Free Cash Flow -$8.884M $13.93M $14.24M
YoY Change 116.68% -371.01% -223.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001396814
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37053372 shares
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
1295479652 USD
CY2015 dei Entity Registrant Name
EntityRegistrantName
Pacira Pharmaceuticals, Inc.
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2014Q4 pcrx Accrued End Of Term Fee Current
AccruedEndOfTermFeeCurrent
1625000 USD
CY2015Q4 pcrx Accrued End Of Term Fee Current
AccruedEndOfTermFeeCurrent
1605000 USD
CY2014Q4 pcrx Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
12094000 USD
CY2015Q4 pcrx Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
14984000 USD
CY2015 pcrx Ageof Children Pediatric Patientsto Study Exparel
AgeofChildrenPediatricPatientstoStudyEXPAREL
P2Y
CY2013 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
459000 USD
CY2014 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
487000 USD
CY2015 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
481000 USD
CY2015 pcrx Amount Received In Lockbox Restricted For Payment Of Royalty Interest
AmountReceivedInLockboxRestrictedForPaymentOfRoyaltyInterest
2500000.0 USD
CY2015 pcrx Beginning Period Prior To Product Expiration Allowed For Returning Product
BeginningPeriodPriorToProductExpirationAllowedForReturningProduct
P6M
CY2013 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
972000 USD
CY2014 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
1287000 USD
CY2015 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
1426000 USD
CY2013 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
0 USD
CY2014 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
345000 USD
CY2015 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
852000 USD
CY2013 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
7133000 USD
CY2014 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
19182000 USD
CY2015 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
27262000 USD
CY2013 pcrx Compensationexpensefromstockoptionsnonemployeeawards
Compensationexpensefromstockoptionsnonemployeeawards
4380000 USD
CY2014 pcrx Compensationexpensefromstockoptionsnonemployeeawards
Compensationexpensefromstockoptionsnonemployeeawards
5295000 USD
CY2015 pcrx Compensationexpensefromstockoptionsnonemployeeawards
Compensationexpensefromstockoptionsnonemployeeawards
2367000 USD
CY2012Q2 pcrx Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition
ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition
2000000 USD
CY2015Q4 pcrx Conversion Request Convertible Senior Notes
ConversionRequestConvertibleSeniorNotes
1500000 USD
CY2015 pcrx Debt Instrument Convertible Conversion Premium Shares
DebtInstrumentConvertibleConversionPremiumShares
3200000.0 shares
CY2015Q4 pcrx Debt Instrument Convertible Conversion Value
DebtInstrumentConvertibleConversionValue
248000000 USD
CY2014Q4 pcrx Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance
DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance
131341000 USD
CY2015Q4 pcrx Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance
DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance
132116000 USD
CY2014Q4 pcrx Deferred Tax Assets Stock Based Compensation
DeferredTaxAssetsStockBasedCompensation
8487000 USD
CY2015Q4 pcrx Deferred Tax Assets Stock Based Compensation
DeferredTaxAssetsStockBasedCompensation
17201000 USD
CY2013 pcrx Effective Income Tax Rate Reconciliation Foreign
EffectiveIncomeTaxRateReconciliationForeign
0.0000
CY2014 pcrx Effective Income Tax Rate Reconciliation Foreign
EffectiveIncomeTaxRateReconciliationForeign
-0.0013
CY2015 pcrx Effective Income Tax Rate Reconciliation Foreign
EffectiveIncomeTaxRateReconciliationForeign
0.1203
CY2013 pcrx Effective Income Tax Rate Reconciliation Interest Expense Percent
EffectiveIncomeTaxRateReconciliationInterestExpensePercent
0.0030
CY2014 pcrx Effective Income Tax Rate Reconciliation Interest Expense Percent
EffectiveIncomeTaxRateReconciliationInterestExpensePercent
0.1068
CY2015 pcrx Effective Income Tax Rate Reconciliation Interest Expense Percent
EffectiveIncomeTaxRateReconciliationInterestExpensePercent
-0.3757
CY2015Q4 pcrx Employee Stock Purchase Plan Espp Sharesin Espp
EmployeeStockPurchasePlanESPPSharesinESPP
500000 shares
CY2015 pcrx Employee Stock Purchase Plan Numberof Shares Authorized
EmployeeStockPurchasePlanNumberofSharesAuthorized
500000 shares
CY2015 pcrx Employee Stock Purchase Plan Numberof Shares Available For Purchase
EmployeeStockPurchasePlanNumberofSharesAvailableForPurchase
449300 shares
CY2015Q4 pcrx Employee Stock Purchase Planfairvalue
EmployeeStockPurchasePlanfairvalue
0.85
CY2013 pcrx Equity Componentof Convertible Debt
EquityComponentofConvertibleDebt
24936000 USD
CY2014 pcrx Equity Componentof Convertible Debt
EquityComponentofConvertibleDebt
0 USD
CY2015 pcrx Equity Componentof Convertible Debt
EquityComponentofConvertibleDebt
0 USD
CY2013 pcrx Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium
FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium
0 USD
CY2014 pcrx Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium
FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium
0 USD
CY2015 pcrx Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium
FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium
3929000 USD
CY2015Q4 pcrx Foreign Property Plantand Equipment Net
ForeignPropertyPlantandEquipmentNet
25900000 USD
CY2014 pcrx Goodwill Recordedfor Earn Out Payments
GoodwillRecordedforEarnOutPayments
5433000 USD
CY2015 pcrx Goodwill Recordedfor Earn Out Payments
GoodwillRecordedforEarnOutPayments
7119000 USD
CY2014 pcrx Goodwill Recordedon Milestone Payments
GoodwillRecordedonMilestonePayments
8000000 USD
CY2013 pcrx Income Lossfrom Continuing Operationsbefore Income Taxes Total
IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal
-64351000 USD
CY2014 pcrx Income Lossfrom Continuing Operationsbefore Income Taxes Total
IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal
-13543000 USD
CY2015 pcrx Income Lossfrom Continuing Operationsbefore Income Taxes Total
IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal
2120000 USD
CY2014 pcrx Income Tax Provision
IncomeTaxProvision
200000 USD
CY2015 pcrx Income Tax Provision
IncomeTaxProvision
300000 USD
CY2013 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
434000 USD
CY2014 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
970000 USD
CY2015 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
276000 USD
CY2013 pcrx Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units
IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits
0 shares
CY2014 pcrx Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units
IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits
0 shares
CY2015 pcrx Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units
IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits
3000 shares
CY2015Q4 pcrx Lease Incentive Utilized
LeaseIncentiveUtilized
4600000 USD
CY2014Q4 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
103376000 USD
CY2015Q4 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
105928000 USD
CY2015 pcrx Maximum Ageof Pediatric Patientsto Study Exparel
MaximumAgeofPediatricPatientstoStudyEXPAREL
P18Y
CY2015Q4 pcrx Maximum Fair Market Value Purchaseof Espp Shares
MaximumFairMarketValuePurchaseofESPPShares
25000 USD
CY2015 pcrx Minimum Ageof Pediatric Patientsto Study Exparel
MinimumAgeofPediatricPatientstoStudyEXPAREL
P12Y
CY2015 pcrx Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax
MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax
0.5
CY2015Q4 pcrx Non Us Net Operating Loss
NonUSNetOperatingLoss
2200000 USD
CY2014 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2015 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2015Q4 pcrx Operating Loss Carryforwards Related To Stock Based Compensation
OperatingLossCarryforwardsRelatedToStockBasedCompensation
72900000 USD
CY2012Q2 pcrx Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition
PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition
10000000 USD
CY2013 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
2031000 USD
CY2014 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
13433000 USD
CY2015 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
7119000 USD
CY2015 pcrx Payment Period Of Royalty Interest From Restricted Amount In Lockbox
PaymentPeriodOfRoyaltyInterestFromRestrictedAmountInLockbox
P12M
CY2015 pcrx Percentage Of Royalty On Sale Of Product
PercentageOfRoyaltyOnSaleOfProduct
0.03
CY2015 pcrx Period After Product Expiration Upto Which Product Is Allowed To Be Returned
PeriodAfterProductExpirationUptoWhichProductIsAllowedToBeReturned
P12M
CY2013Q1 pcrx Proceeds From Sale Of Unused Net Operating Losses
ProceedsFromSaleOfUnusedNetOperatingLosses
400000 USD
CY2013 pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plan
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan
0 USD
CY2014 pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plan
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan
1184000 USD
CY2015 pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plan
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan
2093000 USD
CY2014Q4 pcrx Product Returns Rebatesand Other Fees
ProductReturnsRebatesandOtherFees
2470000 USD
CY2015Q4 pcrx Product Returns Rebatesand Other Fees
ProductReturnsRebatesandOtherFees
3111000 USD
CY2014Q4 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
276000 USD
CY2015Q4 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
0 USD
CY2014Q4 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
276000 USD
CY2015Q4 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
0 USD
CY2015 pcrx Settlement Period Convertible Debt Conversion Request
SettlementPeriodConvertibleDebtConversionRequest
P40D
CY2015Q4 pcrx Sharebased Compensationarrangementby Sharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue
SharebasedCompensationarrangementbySharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue
78.61
CY2015Q4 pcrx Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue
Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue
14920000 USD
CY2015 pcrx Stock Issued During Period Convertible Senior Notes Conversion
StockIssuedDuringPeriodConvertibleSeniorNotesConversion
44287 shares
CY2013 pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
0 USD
CY2014 pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
110452000 USD
CY2015 pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
0 USD
CY2015Q4 pcrx Total Goodwill Recordedfor Earn Out Payments
TotalGoodwillRecordedforEarnOutPayments
14900000 USD
CY2015 pcrx Uncertain Tax Position Recognition Threshold
UncertainTaxPositionRecognitionThreshold
0.500
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6758000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8739000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22366000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25855000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28311000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35375000 USD
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3213000 USD
CY2015Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3731000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20114000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24917000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
481334000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
526696000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
23956000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-4100000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11513000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24822000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33368000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11513000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24822000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33368000 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3959000 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4139000 USD
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4102000 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5378000 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6039000 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1998000 shares
CY2015Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
600000 USD
CY2014Q4 us-gaap Assets
Assets
326072000 USD
CY2015Q4 us-gaap Assets
Assets
389623000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
214257000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
252582000 USD
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
143649000 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
115495000 USD
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
33000 USD
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
93000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
85000 USD
CY2013 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
622000 USD
CY2014 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
-1095000 USD
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
418000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10126000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12515000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37520000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56984000 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.44
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.44
CY2012Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
162885 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7216 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7216 shares
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36150620 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36848319 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36150620 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36848319 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
36000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
37000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63931000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13801000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1884000 USD
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
103100000 USD
CY2015Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
105928000 USD
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
54772000 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
18127000 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
19954000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
20391000 USD
CY2014Q4 us-gaap Cost Of Revenue
CostOfRevenue
18968000 USD
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
18929000 USD
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
77440000 USD
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
17580000 USD
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
15901000 USD
CY2015Q4 us-gaap Cost Of Revenue
CostOfRevenue
19427000 USD
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
71837000 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
92000 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-442000 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
173000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
172000 USD
CY2015Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3200000 shares
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
16900000 USD
CY2015Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
12605000 USD
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
4500000 USD
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
9200000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1426000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1426000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9508000 USD
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
8082000 USD
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
4065000 USD
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3530000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
137624000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
136795000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
111086000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
101011000 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
588000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1045000 USD
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3494000 USD
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1310000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6043000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7140000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3861000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
5558000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
131341000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
132116000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
6283000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
4679000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1000000 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000 USD
CY2013 us-gaap Depreciation
Depreciation
3700000 USD
CY2014 us-gaap Depreciation
Depreciation
9300000 USD
CY2015 us-gaap Depreciation
Depreciation
11200000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5747000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10035000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11475000 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.08
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0069
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0128
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1245
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4291
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1771
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.1032
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0172
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0044
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0726
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0010
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0155
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.1533
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0479
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.3262
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0071
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0169
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0549
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.3063
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8909000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11944000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14597000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14919000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
403000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
81000 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-32000 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-158000 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-6000 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3398000 USD
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-52000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
10328000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
23761000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
30880000 USD
CY2012Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
8000000 USD
CY2015Q4 us-gaap Incentive From Lessor
IncentiveFromLessor
5700000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-64351000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13271000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
4033000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-64351000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13543000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2120000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-272000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1913000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-442000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
173000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
264000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
34000 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
195000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9622000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15349000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9941000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10238000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7776000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3489000 USD
CY2014 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-400000 USD
CY2015 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-400000 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-472000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6713000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1426000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3480000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13706000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32382000 USD
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1047000 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2526000 USD
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5786000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
972000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1621000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2007000 USD
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
110000 USD
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-124000 USD
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1509000 USD
CY2013 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2014 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2015 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
6000 shares
CY2013 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2014 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2015 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
3113000 shares
CY2013 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0 shares
CY2014 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0 shares
CY2015 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
1000 shares
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1638000 shares
CY2013 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1100000 USD
CY2014 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000 USD
CY2015 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
800000 USD
CY2013 us-gaap Interest Expense
InterestExpense
7253000 USD
CY2014 us-gaap Interest Expense
InterestExpense
8278000 USD
CY2015 us-gaap Interest Expense
InterestExpense
7725000 USD
CY2013 us-gaap Interest Paid
InterestPaid
3500000 USD
CY2014 us-gaap Interest Paid
InterestPaid
5193000 USD
CY2015 us-gaap Interest Paid
InterestPaid
4224000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11383000 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
32781000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
29263000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
61645000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9263000 USD
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16712000 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8617000 USD
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12152000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
259000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
382000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
678000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
154927000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
171231000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
326072000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
389623000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
140010000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
151676000 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
103100000 USD
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
105928000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
120000000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
118533000 USD
CY2014Q4 us-gaap Long Term Investments
LongTermInvestments
24431000 USD
CY2015Q4 us-gaap Long Term Investments
LongTermInvestments
13462000 USD
CY2013 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
2389000 USD
CY2014 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
25005000 USD
CY2015 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
19464000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
89165000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
118875000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10699000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-42938000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-120434000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20231000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-43838000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
26564000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
28996000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-63909000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-11477000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-5037000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3004000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
5802000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-13716000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
1260000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
8000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
3086000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-2498000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
1856000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11062000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8378000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7335000 USD
CY2015 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2013 us-gaap Operating Expenses
OperatingExpenses
138840000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
45920000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
50007000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
53033000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
53873000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
202833000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
54975000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
57330000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
57104000 USD
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
70133000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
239542000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-53289000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-5165000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
9455000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
47156000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
7743000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
6420000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
8303000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
8081000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
7878000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
8731000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4900000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4900000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
5700000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2588000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2294000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-85000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
28000 USD
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-85000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
28000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5409000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11473000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-165000 USD
CY2013 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7191000 USD
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2013 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
114299000 USD
CY2014 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
164303000 USD
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
189082000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12172000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22984000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41270000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4461000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6117000 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
120000000 USD
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2014Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
110500000 USD
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
-1467000 USD
CY2013 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
85564000 USD
CY2014 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
80286000 USD
CY2015 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
217240000 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3856000 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7239000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10073000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80746000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
115241000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60632000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
90324000 USD
CY2015Q4 us-gaap Purchase Obligation
PurchaseObligation
900000 USD
CY2013 us-gaap Repayments Of Debt
RepaymentsOfDebt
27500000 USD
CY2015 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21560000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18731000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28662000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1509000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2013 us-gaap Restricted Stock Expense
RestrictedStockExpense
0 USD
CY2014 us-gaap Restricted Stock Expense
RestrictedStockExpense
0 USD
CY2015 us-gaap Restricted Stock Expense
RestrictedStockExpense
2887000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-310145000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-308289000 USD
CY2013 us-gaap Revenues
Revenues
85551000 USD
CY2014Q1 us-gaap Revenues
Revenues
36662000 USD
CY2014Q2 us-gaap Revenues
Revenues
47165000 USD
CY2014Q3 us-gaap Revenues
Revenues
52048000 USD
CY2014Q4 us-gaap Revenues
Revenues
61793000 USD
CY2014 us-gaap Revenues
Revenues
197668000 USD
CY2015Q1 us-gaap Revenues
Revenues
58316000 USD
CY2015Q2 us-gaap Revenues
Revenues
59148000 USD
CY2015Q3 us-gaap Revenues
Revenues
62213000 USD
CY2015Q4 us-gaap Revenues
Revenues
69320000 USD
CY2015 us-gaap Revenues
Revenues
248997000 USD
CY2013 us-gaap Royalty Expense
RoyaltyExpense
623000 USD
CY2014 us-gaap Royalty Expense
RoyaltyExpense
323000 USD
CY2015 us-gaap Royalty Expense
RoyaltyExpense
71000 USD
CY2013 us-gaap Royalty Revenue
RoyaltyRevenue
2623000 USD
CY2014 us-gaap Royalty Revenue
RoyaltyRevenue
2855000 USD
CY2015 us-gaap Royalty Revenue
RoyaltyRevenue
3084000 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
81956000 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
193526000 USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
244487000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62508000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106662000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
139043000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
11513000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
24822000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
33368000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8129537 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
826677 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
7302860 shares
CY2015Q4 us-gaap Share Price
SharePrice
76.79
CY2014Q2 us-gaap Share Price
SharePrice
64.00
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
0 USD
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
16602000 USD
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
119138000 USD
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
101981000 USD
CY2015 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
50700 shares
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1840000 shares
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3929000 USD
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1184000 USD
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2093000 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
110452000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3856000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7239000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10073000 USD
CY2013 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
0 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
65855000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
41249000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
171145000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
218392000 USD
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
139000 USD
CY2015Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
208000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17500000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9900000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
800000 USD
CY2013 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
4029000 USD
CY2014 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
8323000 USD
CY2015 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
10746000 USD
CY2012Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
393000 USD
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1878000 USD
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3043000 USD
CY2014 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
7158000 USD
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33182000 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35299000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41301000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33182000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35299000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36540000 shares
CY2015 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2014-09,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which requires that an entity recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to its customers. In order to achieve this core principle, an entity should apply the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. In August 2015, the FASB issued Accounting Standards Update 2015-14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers: Deferral of the Effective Date</font><font style="font-family:inherit;font-size:10pt;">. This latest standard defers the effective date of revenue standard ASU 2014-09 by one year and permits early adoption on a limited basis. This update will replace existing revenue recognition guidance under GAAP when it becomes effective for the Company beginning January 1, 2018, with early adoption permitted in the first quarter of 2017. The updated standard will permit the use of either the retrospective or cumulative effect transition method. The Company is continuing to evaluate the impact of these updates on its consolidated financial statements.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued ASU 2015-03, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest&#8212;Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs</font><font style="font-family:inherit;font-size:10pt;">, which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset. Debt disclosures will include the face amount of the debt liability and the effective interest rate. The update requires retrospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. The adoption of ASU 2015-03 is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued ASU 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory (Topic 330): Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. The standard requires entities to measure most inventory &#8220;at the lower of cost and net realizable value,&#8221; thereby simplifying the current guidance under which an entity must measure inventory at the lower of cost or market (market in this context is defined as one of three different measures, one of which is net realizable value). The standard is effective for the Company prospectively beginning January 1, 2017. The adoption of ASU 2015-11 is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the FASB issued ASU 2015-17, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes</font><font style="font-family:inherit;font-size:10pt;">. The standard eliminates the current requirement for an entity to separate deferred income tax liabilities and assets into current and non-current amounts in a classified balance sheet. Instead, this guidance requires deferred tax liabilities, deferred tax assets and valuation allowances be classified as non-current in a classified balance sheet. This ASU is effective for annual reporting periods beginning after December 15, 2016 and interim periods within those annual periods. Early adoption is permitted. Additionally, this guidance may be applied either prospectively or retrospectively to all periods presented. The Company is evaluating the impact of ASU 2015-17 on its consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.</font></div></div>
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, impairment of long-lived assets, stock-based compensation and valuation of deferred tax assets. The Company&#8217;s critical accounting policies are those that are both most important to the Company&#8217;s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0001628280-16-011728-index-headers.html Edgar Link pending
0001628280-16-011728-index.html Edgar Link pending
0001628280-16-011728.txt Edgar Link pending
0001628280-16-011728-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
item5chart10ka02.jpg Edgar Link pending
paciraproductsa06.jpg Edgar Link pending
pcrx-12312015x10k.htm Edgar Link pending
pcrx-12312015xex1057.htm Edgar Link pending
pcrx-12312015xex211.htm Edgar Link pending
pcrx-12312015xex231.htm Edgar Link pending
pcrx-12312015xex311.htm Edgar Link pending
pcrx-12312015xex312.htm Edgar Link pending
pcrx-12312015xex321.htm Edgar Link pending
pcrx-12312015xex322.htm Edgar Link pending
pcrx-20151231.xml Edgar Link completed
pcrx-20151231.xsd Edgar Link pending
pcrx-20151231_cal.xml Edgar Link unprocessable
pcrx-20151231_def.xml Edgar Link unprocessable
pcrx-20151231_lab.xml Edgar Link unprocessable
pcrx-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending